ANNOUNCEMENT

MedCity CONVERGE gathers payers, providers, medtech, pharma, digital health, investors, policymakers and more.

Topic: Boston Scientific

Boston Scientific sees market share growth in heart devices

Boston Scientific sees market share growth in heart devices

February 12, 2013 3:48 pm by | 0 Comments

(Reuters) - Medical device maker Boston Scientific Corp said it expects to grow faster than the overall market for implantable heart devices, which has been struggling in recent years amid ... Read more
Boston Scientific to lay off 900 to 1,000 in a bid to save roughly $100 million by year’s end

Boston Scientific to lay off 900 to 1,000 in a bid to save roughly $100 million by year’s end

January 29, 2013 7:44 am by | 0 Comments

In announcing its fourth-quarter earnings Tuesday, Boston Scientific (NYSE:BSX) also announced that it was reducing its workforce by 900 to 1,000 people worldwide, a move that will lower pre-tax operating ... Read more
Lady Luck may shine on Boston Scientific in 2013 if rival’s fortune goes down in flames

Lady Luck may shine on Boston Scientific in 2013 if rival’s fortune goes down in flames

November 26, 2012 12:45 pm by | 0 Comments

It’s not great when a company needs a rival to have a major disaster in order to see the upside, but when you are Boston Scientific (NYSE: BSX), it may ... Read more
BSX’s $300M acquisition of Vessix Vascular shows continued consolidation in renal denervation

BSX’s $300M acquisition of Vessix Vascular shows continued consolidation in renal denervation

November 8, 2012 10:53 am by | 0 Comments

 UPDATED WITH ANALYST COMMENTBoston Scientific (NYSE:BSX) is jumping on the renal denervation bandwagon.The Natick, Massachusetts, medical device manufacturer announced Thursday that it is buying Caifornia startup Vessix Vascular for an ... Read more
Bypass seems safer, more successful than stents for people with diabetes and clogged arteries

Bypass seems safer, more successful than stents for people with diabetes and clogged arteries

November 4, 2012 7:52 pm by | 0 Comments

LOS ANGELES (Reuters) - Diabetics with more than one diseased artery fared significantly better if they underwent bypass surgery than those who received drug coated stents following artery clearing procedures ... Read more
Analyst: New Boston Scientific acquisition will help it to compete better with J&J, St. Jude

Analyst: New Boston Scientific acquisition will help it to compete better with J&J, St. Jude

October 9, 2012 4:00 am by | 0 Comments

Earlier on Monday, Boston Scientific (NYSE:BSX) announced that it is acquiring Rhythmia Medical, which makes 3D navigational software in cardiac procedures to treat variety of conditions including irregular heart beat ... Read more
Boston Sci gets FDA OK of S-ICD system for patients at risk of sudden cardiac arrest

Boston Sci gets FDA OK of S-ICD system for patients at risk of sudden cardiac arrest

September 28, 2012 11:18 pm by | 0 Comments

The U.S. Food and Drug Administration has granted Boston Scientific Corporation (NYSE: BSX) regulatory approval for its S-ICD System, the world's first and only commercially available subcutaneous implantable defibrillator (S-ICD) ... Read more
Analyst: BridgePoint Medical’s acquisition provides “another arrow” in BSX’s cath lab “quiver”

Analyst: BridgePoint Medical’s acquisition provides “another arrow” in BSX’s cath lab “quiver”

September 20, 2012 12:39 pm by | 0 Comments

On Wednesday, after Boston Scientific (NYSE:BSX) announced the acquisition of Minnesota startup BridgePoint Medical, the startup’s CEO said that he is excited by the prospect of having the company’s technology ... Read more
Boston Scientific acquires firm treating total blockage of coronary arteries for undisclosed amount

Boston Scientific acquires firm treating total blockage of coronary arteries for undisclosed amount

September 19, 2012 9:52 am by | 1 Comments

Boston Scientific(NYSE:BSX) announced Wednesday that it is acquiring Minneapolis-based BridgePoint Medical, which has developed minimally invasive technologies to treat complete blockage of the coronary artery or coronary chronic total occlusions.The ... Read more
Appeals court reverses CRT patent infringement ruling in win for Boston Scientific against Medtronic

Appeals court reverses CRT patent infringement ruling in win for Boston Scientific against Medtronic

September 18, 2012 11:45 am by | 0 Comments

WASHINGTON (Reuters) - Boston Scientific Corp won a round in a legal battle with Medtronic Inc on Tuesday over an implantable medical device called a CRT, which gives the heart ... Read more
Analyst: Boston Scientific’s reported split of cardiac business underscores failure of integration

Analyst: Boston Scientific’s reported split of cardiac business underscores failure of integration

August 30, 2012 11:08 am by | 0 Comments

If Boston Scientific (NYSE: BSX) were to break up its cardiac rhythm management business into a cardiac unit and an interventional cardiology unit as Reuters reported, the move will spell ... Read more
Boston Scientific closure device receives CE Mark for expanded use in AF patients

Boston Scientific closure device receives CE Mark for expanded use in AF patients

August 27, 2012 6:08 am by | 0 Comments

European regulators have approved an expanded indication for the Boston Scientific Corporation (NYSE: BSX) WATCHMAN Left Atrial Appendage (LAA) Closure Device. The new indication offers patients with atrial fibrillation (AF), ... Read more
For Boston Scientific, approval of subcutaneous ICD couldn’t come soon enough

For Boston Scientific, approval of subcutaneous ICD couldn’t come soon enough

July 30, 2012 9:34 am by | 0 Comments

For the last year, Boston Scientific’s(NYSE:BSX) stock has hovered between $5 and $6, and no amount of share buybacks have nudged the price up much.In the company’s second-quarter earnings call ... Read more
Boston Scientific CEO as unsure about bottom of global CRM market as St. Jude

Boston Scientific CEO as unsure about bottom of global CRM market as St. Jude

July 26, 2012 10:05 am by | 0 Comments

If people are looking for confirmation that the global cardiac rhythm management market has declined as much as it could and will fall no further, they have to wait a ... Read more
Pain device maker Neuros Medical’s $3.5M round led by Boston Scientific, Glengary

Pain device maker Neuros Medical’s $3.5M round led by Boston Scientific, Glengary

July 18, 2012 4:41 pm by | 0 Comments

Neurostimulation device company Neuros Medical Inc. has landed $3.5 million in its second round of funding from a handful of investors including medical device powerhouse Boston Scientific (NYSE:BSX).The company’s device, ... Read more